SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

July 02, 2012 08:35 ET

MMRGlobal Receives 30-Year Business License to Operate in China

LOS ANGELES, CA--(Marketwire - Jul 2, 2012) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today announced that it has received its official business license from the Chinese government to operate Unis Tonghe MMR International Health Management Service Co., Ltd., a joint venture between Unis-Tonghe Technology (Zhengzhou) Co., Ltd. and MMRGlobal. The JV is officially licensed with the Chinese government and is approved to operate and generate revenue. The license enables the Joint Venture company to develop medical information management software, medical information technology software, health records management systems, and provision of related services, including the Company's Personal Health Record systems. The business will offer its products and services to the Chinese government, hospitals, healthcare facilities and to the public and is valid through 2042 (see attachment).

Bob Lorsch, Chairman and CEO of MMRGlobal, said, "This is a significant development for MMRGlobal and the MMR Unis Joint Venture as we now have the green light to begin selling a suite of health information technology products and services and Personal Health Records into the Chinese market, with a population of almost a billion-and-a-half people. The Chinese government is committed to establishing a healthcare system that utilizes the latest technologies to improve patient care and reduces costs, which MMR is proud to be part of. China is working hard to build complete healthcare solutions, upgrading hospitals and converting to digitized recordkeeping so they have greater capability to track and predict the health needs of its citizens. Our Joint Venture with Unis-Tonghe, which initially offers services in Henan Province with a population of more than 100 million, is already underway and can generate revenue to the Joint Venture. Mr. Luo, Unisoft Group Vice President and Chairman, was our guest in Los Angeles on June 20, where we discussed how we would handle the secure transfer of MMR software, patents and technology for deployment in China in view of the official issuance of our business license through 2042."

About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, whether or not such statement relates directly to the Unis-Tonghe MMR Joint Venture, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "intend," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue." These forward-looking statements are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community in the U.S. and internationally; business prospects, results of operations or financial condition; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships and partnerships; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio both in the U.S. and internationally; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information